PREEMIE: Study for Treatment of PDA in Premature Infants

This multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (P...

Lead sponsor: Merit Medical Systems, Inc.•9 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2/3

Prophylactic IV Paracetamol in Extremely Premature Infants

NCT07067177 · Patent Ductus Arteriosus in Preterm Infants, Patent Ductus Arteriosus After Premature Birth, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 15, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment55

Start dateMar 2025

Last updatedMay 15, 2026

Condition

Patent Ductus Arteriosus (PDA)

Locations shown

UC Davis Health

Sacramento, California

UC San Diego-Rady Children's Hospital

San Diego, California

Memorial Healthcare System-Joe DiMaggio Children's Hospital

Hollywood, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions